Clinical Trials Directory

Trials / Conditions / Hematological Neoplasms

Hematological Neoplasms

10 registered clinical trials studyying Hematological Neoplasms — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingAutologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in
NCT06904066
National Cancer Institute (NCI)Phase 1
RecruitingDistraction With Virtual Reality From Pain and Anxiety for Patients With Hematological Malignancies
NCT07085065
Yesmine AmaraN/A
RecruitingDose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease
NCT03844360
Wei ZhaoPhase 4
CompletedPeg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT
NCT02634294
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 2 / Phase 3
CompletedBioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
CelgenePhase 1
CompletedPegfilgrastim Versus Filgrastim After High-dose Chemotherapy
NCT00410696
Armando Santoro, MDPhase 2
CompletedADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Partic
NCT00440479
Janssen-Cilag B.V.—
CompletedReduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
NCT00582894
University of OklahomaN/A
CompletedVALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bor
NCT00440765
Janssen-Cilag B.V.—
CompletedGranulocyte Transfusions in Hematological Patients With Febrile Neutropenia
NCT02544230
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne—